The effect of popliteal sciatic nerve block with methylprednisolone in the managemenpostinjection sciatic neuropathy after clinical and electrophysiological examination


Creative Commons License

Yürük D., Tabakoğlu A. Y.

Turkish Journal of Medical Sciences, vol.51, no.5, pp.2666-2673, 2021 (SCI-Expanded) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 51 Issue: 5
  • Publication Date: 2021
  • Doi Number: 10.3906/sag-2009-196
  • Journal Name: Turkish Journal of Medical Sciences
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.2666-2673
  • Keywords: Sciatic neuropathy, postinjection neuropathy, popliteal block
  • Open Archive Collection: AVESIS Open Access Collection
  • Ankara Yıldırım Beyazıt University Affiliated: No

Abstract

© TÜBİTAK.Background/aim: This study aimed to investigate the effects of popliteal sciatic nerve block (PSNB) in the treatment of postinjecsciatic neuropathy (PISN) resistant to conservative treatments. Materials and methods: Patients diagnosed with PISN were included in the study. A damaged branch of the sciatic nerve was detected after neurological and electrophysiologic studies (EPSs). Visual analogue scale (VAS) was administered before, one hour after, and one month after the procedure. Also Leeds Assessment of Neuropathic Symptoms and Signs pain scale (LANSS) was administered before and one month after the procedure. The effects of EPSs findings and loss of muscle strength on the VAS and LANSS scores that measured after PSNB were evaluated. Results: PSNB was performed in 17 patients (12 males and 5 females) with a diagnosis of PISN. Their mean age was 54.95 ± 12.55 yeaand the mean duration of symptoms was 3.53 ± 1.28 months. The EPS findings revealed a lateral truncus injury in 5, a medial truncinjury in 3, and injury to both in 9 patients. The initial muscle power scale scores were grade 0 in 2, grade 2 in 1, grade 3 in 7, grade 4 5, and grade 5 in 2 patients. The initial VAS and LANSS scores were 7.53 ± 1.06 and 17.35 ± 3.12. The mean VAS scores at the first hoand one month after the procedure decreased to 2.53 ± 1.70 and 4.18 ± 1.74 while the mean LANSS score one month after the proceduwas reduced to 7.88 ± 5.84. The effects of EPSs findings and loss of muscle strength were found significant (p = 0.001), but the duratiof symptoms was not found significant (p = 0.36) on the VAS and LANSS scores that measured after PSNB. Conclusion: The outcome of this research proved the effectiveness of PSNB with methylprednisolone in the management of PISNespecially in patients whose pain was located below the knee. EPSs findings and loss of muscle strength indicated the severity of thnerve damage affect the success of PSNB in pain management, but the length of time that elapsed after the nerve injury did not.